首页 > 最新文献

Modern technologies in ophtalmology最新文献

英文 中文
Anti-VEGF treatment efficacy for aggressive posterior retinopathy of prematurity 抗vegf治疗侵袭性早产儿后视网膜病变疗效观察
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-392-396
O. V. Kolenko, M. V. Pshenichnov, O.I. Kasura, E. L. Sorokin
Purpose. To evaluate the anti-VEGF therapy efficacy for treatment aggressive posterior retinopathy of prematurity (AP-ROP). Material and methods. 14 children (28 eyes) with APROP, mean gestational age of 27.4 weeks. Birth weight were from 480 to 1360 grams, on average – 972.8 grams. AP-ROP were developed children post-conceptual age (PCA) from 31 to 34 weeks, with an average of 32.2 weeks. Intravitreal injection of ranibizumab was performed no later than one day after the detection of AP-ROP. Results. In 22 (78.5 %) of 28 eyes, only one injection of ranibizumab was required, of which, in 6 eyes, additional laser photocoagulation of the retina was performed after the injection in a period of 14 to 21 days. In the remaining 6 eyes (21.5 %), 2 injections of ranibizumab were required 4 to 8 weeks after the first injection. All 34 injections were completed without complications and were not accompanied by any adverse events in the treated children. Retinal detachment developed in 2 children in 3 eyes (10.7 %): in one child – in both eyes (stage 4A ROP – in one of the eyes, 4B – in the paired one); the second child has stage 4B ROP in one of the eyes. All children after anti-VEGF therapy had not complete fundus vascularization to 65 weeks of PCA. As a rule, the 3rd zone of the fundus remained avascular, but no signs of angiogenesis were observed, which we regarded as regression of disease without complete retinal vascularization. Conclusion. The efficacy of treatment of AP-ROP with anti-VEGF therapy was high and amounted to 89.3 %. In 78.5% of cases, one injection of ranibizumab is sufficient for regression of disease. Given the absence of complete retinal vascularization at 65 weeks of PCA, children undergoing anti-VEGF therapy require longer follow-up due to the possibility of reactivation of ROP later in PCA. Keywords: aggressive posterior retinopathy of prematurity, anti-VEGF therapy
目的。目的评价抗vegf治疗侵袭性早产儿后路视网膜病变(AP-ROP)的疗效。材料和方法。approp患儿14例(28眼),平均胎龄27.4周。出生体重从480克到1360克不等,平均为- 972.8克。AP-ROP的发生时间为31 ~ 34周,平均32.2周。在检测到AP-ROP后不迟于1天进行雷尼单抗玻璃体内注射。结果。在28只眼睛中,22只(78.5%)只需要注射一次雷尼单抗,其中6只眼睛在注射后14至21天内进行了额外的视网膜激光光凝。在其余6只眼(21.5%)中,在第一次注射后4至8周需要注射2次雷尼单抗。所有34次注射均无并发症,治疗儿童中未出现任何不良事件。2名儿童3只眼视网膜脱离(10.7%):1名儿童双眼视网膜脱离(其中一只眼视网膜脱离为4A期,另一只眼视网膜脱离为4B期);第二个孩子的一只眼睛有4B期ROP。所有接受抗vegf治疗的儿童在PCA治疗65周时均未完成眼底血管化。通常眼底第三区仍无血管,但未观察到血管生成的迹象,我们认为这是疾病的消退,没有完全的视网膜血管化。结论。抗vegf治疗AP-ROP疗效高,达89.3%。在78.5%的病例中,一次注射雷尼单抗足以使疾病消退。考虑到在PCA 65周时没有完全的视网膜血管化,接受抗vegf治疗的儿童需要更长的随访时间,因为在PCA后期ROP可能会重新激活。关键词:侵袭性早产儿后视网膜病变,抗vegf治疗
{"title":"Anti-VEGF treatment efficacy for aggressive posterior retinopathy of prematurity","authors":"O. V. Kolenko, M. V. Pshenichnov, O.I. Kasura, E. L. Sorokin","doi":"10.25276/2312-4911-2023-1-392-396","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-392-396","url":null,"abstract":"Purpose. To evaluate the anti-VEGF therapy efficacy for treatment aggressive posterior retinopathy of prematurity (AP-ROP). Material and methods. 14 children (28 eyes) with APROP, mean gestational age of 27.4 weeks. Birth weight were from 480 to 1360 grams, on average – 972.8 grams. AP-ROP were developed children post-conceptual age (PCA) from 31 to 34 weeks, with an average of 32.2 weeks. Intravitreal injection of ranibizumab was performed no later than one day after the detection of AP-ROP. Results. In 22 (78.5 %) of 28 eyes, only one injection of ranibizumab was required, of which, in 6 eyes, additional laser photocoagulation of the retina was performed after the injection in a period of 14 to 21 days. In the remaining 6 eyes (21.5 %), 2 injections of ranibizumab were required 4 to 8 weeks after the first injection. All 34 injections were completed without complications and were not accompanied by any adverse events in the treated children. Retinal detachment developed in 2 children in 3 eyes (10.7 %): in one child – in both eyes (stage 4A ROP – in one of the eyes, 4B – in the paired one); the second child has stage 4B ROP in one of the eyes. All children after anti-VEGF therapy had not complete fundus vascularization to 65 weeks of PCA. As a rule, the 3rd zone of the fundus remained avascular, but no signs of angiogenesis were observed, which we regarded as regression of disease without complete retinal vascularization. Conclusion. The efficacy of treatment of AP-ROP with anti-VEGF therapy was high and amounted to 89.3 %. In 78.5% of cases, one injection of ranibizumab is sufficient for regression of disease. Given the absence of complete retinal vascularization at 65 weeks of PCA, children undergoing anti-VEGF therapy require longer follow-up due to the possibility of reactivation of ROP later in PCA. Keywords: aggressive posterior retinopathy of prematurity, anti-VEGF therapy","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83510040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical case of choroideremia 脉络膜血症1例
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-160-166
Y. Khzardzhan, M.A. Balalina, A. S. Balalin, I. A. Melikhova
Purpose. To present an overview of a choroideremia clinical case. Material and Methods. The article presents a clinical case of a 19-year-old patient with complaints of low distance vision, narrowing of the visual field and nictalopia since childhood. The patient underwent complex ophthalmological examination including visometry, autorefractometry, tonometry, biomicro-ophthalmoscopy with Goldman lens, computer perimetry, optical biometry, optical coherence tomography with angiography function (AngioOCT), fundus photoregistration with autofluorescence, electrophysiological examination (EP). The patient was consulted by a geneticist to confirm the basic diagnosis. Results. Visual acuity: OD = 0.1 Sph -2.0 = 1.0; OS = 0.15 Sph -1.5 = 1.0. The anterior-posterior eyeball size: OD – 24.98 mm, OS – 25.0 mm. Computer perimetry revealed narrowing of visual fields up to 10 degrees in both eyes, which correlated with changes in autofluorescence. According to EP, electrical sensitivity threshold: OD 198 µA, OS 202 µA, electrical lability: OD 37 Hz, OS 35 Hz. High visual acuity with correction in patient C. is caused by the macula condition, according to the results of AngioOCT. The retinal pigment epithelium and chorioid are thin. Chorioid outside the macular area lacks the Sattler's layer. Based on the results of a consultation with a geneticist, a pathogenic variant of the nucleotide sequence was detected in the CHM gene (chrX:85213886). Conclusion. Choroideremia is a rare genetic disease with a specific clinical picture and progressive development of visual disorder. Proper and early diagnosis allows the prevention of the disease, including prenatal diagnosis, and the development of new therapies. Keywords: choroideremia, genetic choroidal diseases, optical coherence tomography, autofluorescence, electrophysiological examination
目的。提出一个脉络膜血症的临床病例概述。材料和方法。本文报告一19岁患者自诉自幼视距低、视野狭窄及近视的临床病例。患者接受了复杂的眼科检查,包括粘度计、自折射计、眼压计、生物显微镜检(Goldman lens)、计算机视距测量、光学生物测量、血管成像功能光学相干断层扫描(AngioOCT)、眼底自荧光光配准、电生理检查(EP)。一位遗传学家咨询了病人,以确认基本诊断。结果。视力:OD = 0.1 Sph -2.0 = 1.0;OS = 0.15 Sph -1.5 = 1.0。眼球前后大小:外径- 24.98 mm,正中- 25.0 mm。计算机视野检查显示双眼视野变窄达10度,这与自身荧光的变化相关。根据EP,电灵敏度阈值:OD 198µA, OS 202µA,电稳定性:OD 37 Hz, OS 35 Hz。根据AngioOCT结果,患者c的高视力矫正是由黄斑状况引起的。视网膜色素上皮和脉络膜薄。黄斑区外的绒毛膜缺乏萨特勒氏层。根据与遗传学家咨询的结果,在CHM基因(chrX:85213886)中检测到核苷酸序列的致病性变异。结论。脉络膜血症是一种罕见的遗传性疾病,具有特殊的临床表现和进行性发展的视觉障碍。适当和早期诊断可以预防该疾病,包括产前诊断和开发新的治疗方法。关键词:脉络膜血症,遗传性脉络膜疾病,光学相干断层扫描,自身荧光,电生理检查
{"title":"A clinical case of choroideremia","authors":"Y. Khzardzhan, M.A. Balalina, A. S. Balalin, I. A. Melikhova","doi":"10.25276/2312-4911-2023-1-160-166","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-160-166","url":null,"abstract":"Purpose. To present an overview of a choroideremia clinical case. Material and Methods. The article presents a clinical case of a 19-year-old patient with complaints of low distance vision, narrowing of the visual field and nictalopia since childhood. The patient underwent complex ophthalmological examination including visometry, autorefractometry, tonometry, biomicro-ophthalmoscopy with Goldman lens, computer perimetry, optical biometry, optical coherence tomography with angiography function (AngioOCT), fundus photoregistration with autofluorescence, electrophysiological examination (EP). The patient was consulted by a geneticist to confirm the basic diagnosis. Results. Visual acuity: OD = 0.1 Sph -2.0 = 1.0; OS = 0.15 Sph -1.5 = 1.0. The anterior-posterior eyeball size: OD – 24.98 mm, OS – 25.0 mm. Computer perimetry revealed narrowing of visual fields up to 10 degrees in both eyes, which correlated with changes in autofluorescence. According to EP, electrical sensitivity threshold: OD 198 µA, OS 202 µA, electrical lability: OD 37 Hz, OS 35 Hz. High visual acuity with correction in patient C. is caused by the macula condition, according to the results of AngioOCT. The retinal pigment epithelium and chorioid are thin. Chorioid outside the macular area lacks the Sattler's layer. Based on the results of a consultation with a geneticist, a pathogenic variant of the nucleotide sequence was detected in the CHM gene (chrX:85213886). Conclusion. Choroideremia is a rare genetic disease with a specific clinical picture and progressive development of visual disorder. Proper and early diagnosis allows the prevention of the disease, including prenatal diagnosis, and the development of new therapies. Keywords: choroideremia, genetic choroidal diseases, optical coherence tomography, autofluorescence, electrophysiological examination","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88765105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical case of a combination of congenital toxoplasmosis associated with HIV and cytomegalovirus infections 先天性弓形虫病合并HIV和巨细胞病毒感染1例
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-387-391
O.V. Vaserchuck, Y. V. Mikhelsone, Y. S. Livadarova, T. Y. Dorofeeva, Y.G. Osipova
Toxoplasmosis is one of the problems of medicine, which has serious socio-economic significance. Congenital toxoplasmosis is manifested by severe fetal damage, its chronic course with lifelong preservation of the parasite in various organs and tissues, as well as the possibility of adverse perinatal outcomes. Purpose. To present a clinical case of congenital toxoplasmosis in a child: intrauterine chorioretinitis, meningoencephalitis in combination with HIV infection and current cytomegalovirus infection. Material and methods. A patient transferred from the Ust-Ilimsky maternity hospital to the city of Ivano-Matreninsky Children's Clinical Hospital in Irkutsk. Clinical data: in an HIV-infected mother, from 4 pregnancies, 4 births, a child was born at 39–40 weeks, 2930 gr. Results. Based on the conducted studies and examinations, the child was diagnosed with: Basic: Congenital toxoplasmosis: transferred intrauterine chorioretinitis, meningoencephalitis with the formation of calcifications of cerebral vessels, ventriculomegaly. Related: 1) HIV infection, stage 2 B, progression phase on ART, IC+2, moderate immunodeficiency; 2) Congenital cytomegalovirus infection; 3) UPU. Muscular DMZHP. Ltd. CH0; 4) Normochromic anemia of moderate severity. Conclusions. Congenital toxoplasmosis remains one of the serious problems and requires in-depth study. As a prevention of the development of congenital toxoplasmosis, it is necessary to diagnose infection with toxoplasmosis in women of fertile age during family planning. Keywords: congenital toxoplasmosis, chorioretinitis, meningoencephalitis, HIV infection, CMV infection
弓形虫病是医学问题之一,具有严重的社会经济意义。先天性弓形虫病表现为严重的胎儿损害,其慢性病程伴有寄生虫在各器官和组织中的终身保存,以及不良围产期结局的可能性。目的。报告1例先天性弓形虫病患儿:宫内绒毛膜视网膜炎、脑膜脑炎合并HIV感染和当前巨细胞病毒感染。材料和方法。一名从乌斯特-伊利姆斯基妇产医院转到伊尔库茨克伊万诺-马列连斯基儿童临床医院的病人。临床资料:在一名感染艾滋病毒的母亲中,4次怀孕,4次分娩,在39-40周出生一名婴儿,2930克。根据所做的研究和检查,诊断为:基本:先天性弓形虫病:转移性宫内脉络膜视网膜炎,脑膜脑炎伴脑血管钙化形成,脑室肿大。相关:1)HIV感染,2b期,ART进展期,IC+2,中度免疫缺陷;2)先天性巨细胞病毒感染;3)万国邮联。肌肉DMZHP。有限公司CH0;4)中度正色性贫血。结论。先天性弓形虫病仍然是一个严重的问题,需要深入研究。作为预防先天性弓形虫病的发展,有必要在计划生育期间对育龄妇女进行弓形虫感染诊断。关键词:先天性弓形虫病,绒毛膜视网膜炎,脑膜脑炎,HIV感染,巨细胞病毒感染
{"title":"A clinical case of a combination of congenital toxoplasmosis associated with HIV and cytomegalovirus infections","authors":"O.V. Vaserchuck, Y. V. Mikhelsone, Y. S. Livadarova, T. Y. Dorofeeva, Y.G. Osipova","doi":"10.25276/2312-4911-2023-1-387-391","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-387-391","url":null,"abstract":"Toxoplasmosis is one of the problems of medicine, which has serious socio-economic significance. Congenital toxoplasmosis is manifested by severe fetal damage, its chronic course with lifelong preservation of the parasite in various organs and tissues, as well as the possibility of adverse perinatal outcomes. Purpose. To present a clinical case of congenital toxoplasmosis in a child: intrauterine chorioretinitis, meningoencephalitis in combination with HIV infection and current cytomegalovirus infection. Material and methods. A patient transferred from the Ust-Ilimsky maternity hospital to the city of Ivano-Matreninsky Children's Clinical Hospital in Irkutsk. Clinical data: in an HIV-infected mother, from 4 pregnancies, 4 births, a child was born at 39–40 weeks, 2930 gr. Results. Based on the conducted studies and examinations, the child was diagnosed with: Basic: Congenital toxoplasmosis: transferred intrauterine chorioretinitis, meningoencephalitis with the formation of calcifications of cerebral vessels, ventriculomegaly. Related: 1) HIV infection, stage 2 B, progression phase on ART, IC+2, moderate immunodeficiency; 2) Congenital cytomegalovirus infection; 3) UPU. Muscular DMZHP. Ltd. CH0; 4) Normochromic anemia of moderate severity. Conclusions. Congenital toxoplasmosis remains one of the serious problems and requires in-depth study. As a prevention of the development of congenital toxoplasmosis, it is necessary to diagnose infection with toxoplasmosis in women of fertile age during family planning. Keywords: congenital toxoplasmosis, chorioretinitis, meningoencephalitis, HIV infection, CMV infection","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75205802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical coherence tomography for differential diagnosis of retinal detachment in partial hemophhtalmos and assessment of disease dynamic 光学相干断层扫描对部分血眼视网膜脱离的鉴别诊断及疾病动态评估
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-241-245
Hemophthalmos is one of the urgent conditions in ophthamology. Diagnosis of acute vitreous hemorrhage includes an examination of the fundus, however, a decrease in the transparency of optical media makes it difficult to establish the cause and choose the appropriate management method. OCT allows, mutually with other methods, to visualize the necessary retina area with moderate or even severe opacities caused by hemophthalmos. Keywords: hemophthalmos, optical coherence tomography, peripheral retinas, retinal detachment
眼出血是眼科急症之一。急性玻璃体出血的诊断包括眼底检查,然而,光学介质透明度的降低使其难以确定原因和选择适当的处理方法。OCT可以与其他方法一起,对因眼球出血引起的中度甚至重度混浊的必要视网膜区域进行可视化。关键词:眼出血,光学相干断层扫描,周围视网膜,视网膜脱离
{"title":"Optical coherence tomography for differential diagnosis of retinal detachment in partial hemophhtalmos and assessment of disease dynamic","authors":"","doi":"10.25276/2312-4911-2023-1-241-245","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-241-245","url":null,"abstract":"Hemophthalmos is one of the urgent conditions in ophthamology. Diagnosis of acute vitreous hemorrhage includes an examination of the fundus, however, a decrease in the transparency of optical media makes it difficult to establish the cause and choose the appropriate management method. OCT allows, mutually with other methods, to visualize the necessary retina area with moderate or even severe opacities caused by hemophthalmos. Keywords: hemophthalmos, optical coherence tomography, peripheral retinas, retinal detachment","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73624408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Algorithm of managing patients with exudative form of age-related macular degeneration with resistance to one of the anti-VEGF drugs 对一种抗vegf药物耐药的年龄相关性黄斑变性渗出性患者的管理算法
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-294-297
M. Budzinskaya, A. Plyukhova, O. A. Savochkina, M. A. Afanasiev, P. A. Sorokin
The exudative form of AMD can develop suddenly, leading within a few weeks or months to the death of photoreceptors, a sharp decrease in BCVA and persistent central scotoma. Despite significant progress in the treatment of neovascular AMD associated with the introduction of anti-VEGF drugs into clinical practice, a number of patients have an insufficient response or its absence with standard administration regimens, and sometimes a decrease in the therapeutic effect after repeated intravitreal injections [1, 2]. Purpose. To development management tactics for patients resistant to one of the anti-VEGF drugs. Material and мethod. This study included 25 patients with a diagnosis of exudative AMD who received Aflibercept in the treat & extend regimen for a year, without a significant effect (persistence of intraretinal, subretinal and/or fluid under RP). Patients were switched to brolucizumab. The mean maximum correctable visual acuity in patients treated with aflibercept before switching drugs was 0.41 ± 0.11. The mean number of injections during the first year in the aflibercept group was 7.1 and 6.8 after switching to brolucizumab. The maximum correctable visual acuity at the end of 1 year of treatment with brolucizumab was 0.47 ± 0.1. Before the start of treatment with aflibercept, the mean CRT was 435.2 ± 119.8, at the end of the first year of treatment 403.3 ± 115.9, before 1 intravitreal injection of brolucizumab 407.2 ± 119.3 and 1 year after the start of therapy 357.6 ± 111.4 (p = 0.042). A statistical difference was found between the preparations and the height of the detachment of the retinal pigment epithelium at the end of the first year of treatment. Changes in the height of detachment of the retinal pigment epithelium in 3 eyes (12 %) were not observed when changing the drug. A positive response to drug switching should be noted, although it cannot be overlooked that there are patients who are resistant to anti-VEGF therapy per se. Keywords: the exudative form of AMD, anti-VEGF drugs, neovascular AMD.
AMD的渗出形式可突然发生,在几周或几个月内导致光感受器死亡,BCVA急剧下降和持续的中心暗斑。尽管随着抗vegf药物的引入,在治疗新生血管性AMD方面取得了重大进展,但许多患者在标准给药方案下反应不足或无反应,有时反复玻璃体内注射后治疗效果下降[1,2]。目的。制定抗vegf药物耐药患者的管理策略。材料和мethod。本研究包括25例诊断为渗出性AMD的患者,他们在治疗和延长方案中接受了afliberept一年,没有明显的效果(RP下视网膜内、视网膜下和/或液体的持续存在)。患者转而使用brolucizumab。转换药物前使用阿非利西普的患者平均最大可矫正视力为0.41±0.11。转换为brolucizumab后,afliberept组第一年的平均注射次数为7.1次和6.8次。勃鲁单抗治疗1年后的最大可矫正视力为0.47±0.1。开始阿非利西普治疗前,平均CRT为435.2±119.8,治疗1年结束时为403.3±115.9,1次玻璃体内注射brolucizumab前为407.2±119.3,治疗1年后为357.6±111.4 (p = 0.042)。在治疗的第一年结束时,在制备和视网膜色素上皮脱离的高度之间发现了统计学差异。3只眼(12%)的视网膜色素上皮脱离高度在改变药物时未见变化。应该注意到对药物转换的积极反应,尽管不能忽视的是,有些患者本身对抗vegf治疗具有耐药性。关键词:渗出型AMD,抗vegf药物,新生血管性AMD。
{"title":"Algorithm of managing patients with exudative form of age-related macular degeneration with resistance to one of the anti-VEGF drugs","authors":"M. Budzinskaya, A. Plyukhova, O. A. Savochkina, M. A. Afanasiev, P. A. Sorokin","doi":"10.25276/2312-4911-2023-1-294-297","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-294-297","url":null,"abstract":"The exudative form of AMD can develop suddenly, leading within a few weeks or months to the death of photoreceptors, a sharp decrease in BCVA and persistent central scotoma. Despite significant progress in the treatment of neovascular AMD associated with the introduction of anti-VEGF drugs into clinical practice, a number of patients have an insufficient response or its absence with standard administration regimens, and sometimes a decrease in the therapeutic effect after repeated intravitreal injections [1, 2]. Purpose. To development management tactics for patients resistant to one of the anti-VEGF drugs. Material and мethod. This study included 25 patients with a diagnosis of exudative AMD who received Aflibercept in the treat & extend regimen for a year, without a significant effect (persistence of intraretinal, subretinal and/or fluid under RP). Patients were switched to brolucizumab. The mean maximum correctable visual acuity in patients treated with aflibercept before switching drugs was 0.41 ± 0.11. The mean number of injections during the first year in the aflibercept group was 7.1 and 6.8 after switching to brolucizumab. The maximum correctable visual acuity at the end of 1 year of treatment with brolucizumab was 0.47 ± 0.1. Before the start of treatment with aflibercept, the mean CRT was 435.2 ± 119.8, at the end of the first year of treatment 403.3 ± 115.9, before 1 intravitreal injection of brolucizumab 407.2 ± 119.3 and 1 year after the start of therapy 357.6 ± 111.4 (p = 0.042). A statistical difference was found between the preparations and the height of the detachment of the retinal pigment epithelium at the end of the first year of treatment. Changes in the height of detachment of the retinal pigment epithelium in 3 eyes (12 %) were not observed when changing the drug. A positive response to drug switching should be noted, although it cannot be overlooked that there are patients who are resistant to anti-VEGF therapy per se. Keywords: the exudative form of AMD, anti-VEGF drugs, neovascular AMD.","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85304899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined approach to the treatment of anisometropic amblyopia in children (a clinical case) 综合方法治疗儿童屈光参差性弱视1例
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-438-441
A clinical case of patient K., 12 years old, with a diagnosis of anisometropia, anisometropic amblyopia, mixed astigmatism of the right eye, mild myopia, complex myopic astigmatism of the left eye is presented. Due to the intolerance of eyeglass and contact correction, the preservation of residual amblyopia against the background of regularly performed pleoptic treatment, the patient underwent laser refractive surgery of the amblyopic eye by Femto LASIK method in order to eliminate aniseikonia, which made it possible to successfully select glasses for permanent wearing with correction of the myopic eye and carry out further treatment in conditions of free haploscopy on a binarimeter with obtaining a high functional result. When observed in dynamics after 1 month and six months, the stability of anatomical and functional indicators was noted, which makes it possible to consider a highly effective combined approach in the treatment of anisometropic form of amblyopia in children. Keywords: amblyopia, children, anisometropia, FemtoLASIK, binarimetry
患者K., 12岁,临床诊断为屈光参差、屈光参差弱视、右眼混合性散光、轻度近视、左眼复杂近视散光。由于配镜和接触矫正的不耐受,在定期进行视光治疗的背景下保留残余弱视,患者采用Femto LASIK方法对弱视进行激光屈光手术,以消除斜视。这使得成功选择永久佩戴的眼镜矫正近视成为可能,并在自由单倍镜条件下进行进一步治疗,并获得较高的功能效果。在1个月和6个月后的动态观察中,解剖和功能指标的稳定性被注意到,这使得考虑一种高效的联合方法治疗儿童屈光参差型弱视成为可能。关键词:弱视;儿童;屈光参差
{"title":"Combined approach to the treatment of anisometropic amblyopia in children (a clinical case)","authors":"","doi":"10.25276/2312-4911-2023-1-438-441","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-438-441","url":null,"abstract":"A clinical case of patient K., 12 years old, with a diagnosis of anisometropia, anisometropic amblyopia, mixed astigmatism of the right eye, mild myopia, complex myopic astigmatism of the left eye is presented. Due to the intolerance of eyeglass and contact correction, the preservation of residual amblyopia against the background of regularly performed pleoptic treatment, the patient underwent laser refractive surgery of the amblyopic eye by Femto LASIK method in order to eliminate aniseikonia, which made it possible to successfully select glasses for permanent wearing with correction of the myopic eye and carry out further treatment in conditions of free haploscopy on a binarimeter with obtaining a high functional result. When observed in dynamics after 1 month and six months, the stability of anatomical and functional indicators was noted, which makes it possible to consider a highly effective combined approach in the treatment of anisometropic form of amblyopia in children. Keywords: amblyopia, children, anisometropia, FemtoLASIK, binarimetry","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83801882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unique Pathological and Physiological Angiogenesis of ROP in Safety Aspects of Selective Anti-VEGF Therapy 在选择性抗vegf治疗的安全性方面,ROP独特的病理和生理血管生成
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-235-240
ROP in the developing retina of premature infants is unique because of the coexistence of physiological and pathological angiogenesis. The type of structure of the vascular nodes is the way to understand the selective treatment of ROP. Purpose. Identification of criteria for the selective ROP treatment choice using the type of pathological vasculogenesis. Material and methods. The study included 279 patients with ROP – 1 group (stage I), 152 (304 eyes); group 2 (stage II) – 45 (90 eyes); 3 group (III stage) – 8 (12 eyes); group 4 (IVA stage) –7 (8 eyes); 5 group (posterior aggressive ROP) – 7 (14 eyes); group 6 (immature retina) 60 (120 eyes) – control; 231 (188 eyes) patients with ROP referred for surgical treatment, divided into subgroups before and after lasercoagulation of the retina. Fractal dimension (Df) and complexity of vascular system (СVS) on wide-field images were assessed. Results. In the group before treatment Df 1.4374 ± 0.03, CVS 2.8 ± 0.14, in the group after treatment Df 1.3756 ± 0.03, CVS 2.3 ± 0.21. According to the morphometric data of 12 images, Df (p = 0.004) and CCC (p = 0.02) values were statistically different in subgroups before and after treatment. Low values of Df (< 1.34) may indicate a more pronounced shift of angiogenesis towards pathological, since normally Df of the formed vasculature is 1.7. In this case, it is preferable to use anti-VEGF therapy. Conclusion. The Df and CVS are indicators are relevant parameters for evaluating the effectiveness of laser treatment in patients with ROP. Vascular patterns are unique for each post-conceptual age, CVS and Df are potential markers of the balance between pathological and physiological angiogenesis for the selective choice of ROP therapy. Keywords: retinopathy of prematurity, retinal laser photocoagulation, retinal vascular system, antiVEGF
由于生理性和病理性血管生成并存,早产儿视网膜发育中的ROP是独特的。血管结的结构类型是了解ROP选择性治疗的依据。目的。使用病理性血管发生类型确定选择性ROP治疗选择的标准。材料和方法。本研究纳入ROP - 1组(I期)279例,152例(304只眼);第二组(II期):45只(90只眼);3组(III期)- 8只(12眼);4组(IVA期)-7组(8眼);5组(后侵性ROP) - 7(14眼);6组(未成熟视网膜)60只(120只眼)-对照;231例(188眼)ROP患者行手术治疗,分为视网膜激光凝固前后亚组。对宽视场图像的分形维数(Df)和血管系统复杂度(СVS)进行了评价。结果。治疗前组Df为1.4374±0.03,CVS为2.8±0.14,治疗后组Df为1.3756±0.03,CVS为2.3±0.21。根据12张图像的形态计量学数据,治疗前后各亚组间Df (p = 0.004)、CCC (p = 0.02)值差异有统计学意义。Df值较低(< 1.34)可能表明血管生成更明显地向病理性转变,因为通常形成的血管的Df为1.7。在这种情况下,最好使用抗vegf治疗。结论。Df和CVS是评价激光治疗ROP患者疗效的指标和相关参数。每个怀孕后年龄的血管模式都是独特的,CVS和Df是病理和生理性血管生成平衡的潜在标志,可用于选择性选择ROP治疗。关键词:早产儿视网膜病变,视网膜激光光凝,视网膜血管系统,抗vegf
{"title":"Unique Pathological and Physiological Angiogenesis of ROP in Safety Aspects of Selective Anti-VEGF Therapy","authors":"","doi":"10.25276/2312-4911-2023-1-235-240","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-235-240","url":null,"abstract":"ROP in the developing retina of premature infants is unique because of the coexistence of physiological and pathological angiogenesis. The type of structure of the vascular nodes is the way to understand the selective treatment of ROP. Purpose. Identification of criteria for the selective ROP treatment choice using the type of pathological vasculogenesis. Material and methods. The study included 279 patients with ROP – 1 group (stage I), 152 (304 eyes); group 2 (stage II) – 45 (90 eyes); 3 group (III stage) – 8 (12 eyes); group 4 (IVA stage) –7 (8 eyes); 5 group (posterior aggressive ROP) – 7 (14 eyes); group 6 (immature retina) 60 (120 eyes) – control; 231 (188 eyes) patients with ROP referred for surgical treatment, divided into subgroups before and after lasercoagulation of the retina. Fractal dimension (Df) and complexity of vascular system (СVS) on wide-field images were assessed. Results. In the group before treatment Df 1.4374 ± 0.03, CVS 2.8 ± 0.14, in the group after treatment Df 1.3756 ± 0.03, CVS 2.3 ± 0.21. According to the morphometric data of 12 images, Df (p = 0.004) and CCC (p = 0.02) values were statistically different in subgroups before and after treatment. Low values of Df (< 1.34) may indicate a more pronounced shift of angiogenesis towards pathological, since normally Df of the formed vasculature is 1.7. In this case, it is preferable to use anti-VEGF therapy. Conclusion. The Df and CVS are indicators are relevant parameters for evaluating the effectiveness of laser treatment in patients with ROP. Vascular patterns are unique for each post-conceptual age, CVS and Df are potential markers of the balance between pathological and physiological angiogenesis for the selective choice of ROP therapy. Keywords: retinopathy of prematurity, retinal laser photocoagulation, retinal vascular system, antiVEGF","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80959748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substantiation of pathogenetic orientationtion of staged light immobilization in macular and vitreoretilinal surgery 黄斑和玻璃体视网膜手术中分阶段光固定的病理定位的证实
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-312-318
I. Kornilovskiy
Purpose. To substantiate the pathogenetic orientation of staged light immobilization in macular and vitreoretinal surgery. Material and methods. Literature data and own longterm clinical observations of the results of vitreoretinal, optoreconstructive, microsurgical and laser therapeutic, optical and refractive operations were analyzed. Particular emphasis was placed on the results of photostress-testing and differential aberrometry in macular and vitreoretinal pathology in combination with ametropia (150 eyes, 96 patients). Results. Studies have shown that changes in the retina and surgical operations for macular and vitreoretinal pathology create conditions, when the usual physiological light load begins to have a damaging effect on the retina and aggravate the course of the disease. The latter indicates the expediency of using various techniques for limiting the light load on the retina. This requires a gradual smooth transition from complete to various options for partial light immobilization. In all cases, optical photoprotection from external UV radiation, complete correction of ametropia and associated optical aberrations were shown This was indicated by a positive correlation between defocus and higher-order aberrations with an increase in visual acuity recovery time after a photostress-test. The timing of such immobilization should take into account the severity of the pathological process and the specific type of surgical intervention. This can be realized with a large arsenal of spectacle, contact, intraocular photochromic and spectral lenses that block the violet rays of visible light and attenuate the flow of rays of the blue spectral range. If full optical correction of ametropia, induced irregular astigmatism and higher order aberrations is impossible, their personalized laser correction is shown according to keratotopography and aberrometry data. This is indicated by the revealed positive correlation between the recovery time of visual acuity after the photostress-test, defocus, and higher-order aberrations. Conclusion. Gradual light immobilization in macular and vitreo-retinal surgery has a pathogenetic focus and should be more widely used in ophthalmic practice. Keywords: light immobilization, deprivation, photoprotection, macular and vitreo-retinal surgery
目的。目的:探讨黄斑和玻璃体视网膜手术中分阶段光固定的病理定位。材料和方法。对文献资料及本人对玻璃体视网膜、光重建、显微外科和激光治疗、光学和屈光手术的长期临床观察结果进行分析。特别强调在黄斑和玻璃体视网膜病变合并屈光不正(150眼,96例)的光应力测试和鉴别像差测量结果。结果。研究表明,视网膜的改变和黄斑和玻璃体视网膜病变的外科手术创造了条件,当通常的生理轻负荷开始对视网膜产生破坏性影响并加剧疾病的进程。后者表明使用各种技术来限制视网膜上的轻负荷的便利性。这需要逐步平稳过渡,从完全到各种选择的部分轻固定。在所有病例中,均显示出外部紫外线辐射的光学光保护、屈光不正和相关光学像差的完全矫正。这表明,光应力测试后,离焦和高阶像差与视力恢复时间的增加呈正相关。这种固定的时机应考虑到病理过程的严重程度和手术干预的具体类型。这可以通过大量的眼镜、隐形眼镜、眼内光致变色镜片和光谱镜片来实现,这些镜片可以阻挡可见光的紫色光线,并减弱蓝色光谱范围内的光线流。如果不可能对屈光不正、诱导不规则散光和高阶像差进行全光学校正,则根据角膜地形学和像差测量数据显示其个性化激光校正。光应力测试后的视力恢复时间、离焦与高阶像差呈正相关。结论。在黄斑和玻璃体视网膜手术中,渐进光固定具有发病焦点,应在眼科实践中得到更广泛的应用。关键词:光固定,剥夺,光保护,黄斑和玻璃体视网膜手术
{"title":"Substantiation of pathogenetic orientationtion of staged light immobilization in macular and vitreoretilinal surgery","authors":"I. Kornilovskiy","doi":"10.25276/2312-4911-2023-1-312-318","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-312-318","url":null,"abstract":"Purpose. To substantiate the pathogenetic orientation of staged light immobilization in macular and vitreoretinal surgery. Material and methods. Literature data and own longterm clinical observations of the results of vitreoretinal, optoreconstructive, microsurgical and laser therapeutic, optical and refractive operations were analyzed. Particular emphasis was placed on the results of photostress-testing and differential aberrometry in macular and vitreoretinal pathology in combination with ametropia (150 eyes, 96 patients). Results. Studies have shown that changes in the retina and surgical operations for macular and vitreoretinal pathology create conditions, when the usual physiological light load begins to have a damaging effect on the retina and aggravate the course of the disease. The latter indicates the expediency of using various techniques for limiting the light load on the retina. This requires a gradual smooth transition from complete to various options for partial light immobilization. In all cases, optical photoprotection from external UV radiation, complete correction of ametropia and associated optical aberrations were shown This was indicated by a positive correlation between defocus and higher-order aberrations with an increase in visual acuity recovery time after a photostress-test. The timing of such immobilization should take into account the severity of the pathological process and the specific type of surgical intervention. This can be realized with a large arsenal of spectacle, contact, intraocular photochromic and spectral lenses that block the violet rays of visible light and attenuate the flow of rays of the blue spectral range. If full optical correction of ametropia, induced irregular astigmatism and higher order aberrations is impossible, their personalized laser correction is shown according to keratotopography and aberrometry data. This is indicated by the revealed positive correlation between the recovery time of visual acuity after the photostress-test, defocus, and higher-order aberrations. Conclusion. Gradual light immobilization in macular and vitreo-retinal surgery has a pathogenetic focus and should be more widely used in ophthalmic practice. Keywords: light immobilization, deprivation, photoprotection, macular and vitreo-retinal surgery","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82709326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-port vitreomacular surgery in the treatment of patients with epiretinal fibrosis 双孔玻璃体黄斑手术治疗视网膜前纤维化
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-42-47
Perpose. To present a method of two-port vitrectomy in treatment of patients with epiretinal fibrosis. Material and methods. Two-port vitrectomy method was used to treat patients with idiopathic epiretinal fibrosis. The group included 25 patients (25 eyes) – 16 (64 %) women and 9 (36 %) men. The mean age of the patients was 61 ± 6.4 years. Exclusion criteria were glaucoma and concomitant retinal pathology. The mean value of best corrected visual acuity was 0.28 ± 0.07. The mean retinal thickness in the fovea was 417 ± 70 µm. Vitrectomy was performed with installation of two ports in the opposite quadrants – in the lower half for high-flow cannula (illuminator-chandelier built with infusion cannula), in the upper half for vitrectomy cutter and instruments. The High-Flow infusion cannula (Synergetics) integrated with the mercury vapor illuminator-chandelier is connected to the Photon II illumination system (Synergetics). Surgery was performed classically: central vitrectomy, separation of posterior hyaloid membrane, staining of membranes with vitral dye, membrane removal, tamponade ⅓ of vitreous cavity with sterile air. The average operation time was 18 minutes. Results. Six months after the operative treatment all patients noted reduction of visual discomfort and severity of metamorphopsies. Best corrected visual acuity was increased – 0.58 ± 0.1 (p ≤ 0,05 vs. preoperative values). Average retinal thickness in the fovea after surgical treatment decreased to 261 ± 25 µm according to macular OCT chart (p = 0.03). FCM readings were consistent with preoperative 5.1 ± 2.3 f/ms (p ≤ 0.01). Conclusion. The method of two-port vitrectomy with the use of mercury vapor chandeleur in the treatment of vitreomacular pathology allows safe and effective macular surgery. Keywords: retinophototoxicity, vitrectomy, epiretinal fibrosis
辩护。目的:介绍一种双孔玻璃体切除术治疗视网膜前纤维化的方法。材料和方法。采用双孔玻璃体切除术治疗特发性视网膜前纤维化。该组包括25例患者(25只眼),其中16例(64%)为女性,9例(36%)为男性。患者平均年龄61±6.4岁。排除标准为青光眼及伴发视网膜病变。最佳矫正视力平均值为0.28±0.07。视网膜中央窝平均厚度为417±70µm。玻璃体切除术在相对象限安装两个端口-下半部分用于高流量套管(带有输液套管的照明吊灯),上半部分用于玻璃体切除术切割器和器械。高流量输液插管(synergy)与汞蒸气照明灯-吊灯集成,连接到Photon II照明系统(synergy)。手术方法:中央玻璃体切除术、后玻璃体膜分离、玻璃体染色、去膜、无菌空气填塞1 / 3玻璃体腔。平均手术时间18分钟。结果。手术治疗6个月后,所有患者视力不适减轻,变形严重程度减轻。最佳矫正视力提高- 0.58±0.1(与术前相比p≤0.05)。黄斑OCT图显示,手术后视网膜中央凹平均厚度降至261±25µm (p = 0.03)。FCM读数与术前(5.1±2.3 f/ms)一致(p≤0.01)。结论。采用汞蒸汽吊灯双孔玻璃体切除术治疗玻璃体黄斑病变是安全有效的黄斑手术。关键词:视网膜光毒性,玻璃体切除术,视网膜前纤维化
{"title":"Two-port vitreomacular surgery in the treatment of patients with epiretinal fibrosis","authors":"","doi":"10.25276/2312-4911-2023-1-42-47","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-42-47","url":null,"abstract":"Perpose. To present a method of two-port vitrectomy in treatment of patients with epiretinal fibrosis. Material and methods. Two-port vitrectomy method was used to treat patients with idiopathic epiretinal fibrosis. The group included 25 patients (25 eyes) – 16 (64 %) women and 9 (36 %) men. The mean age of the patients was 61 ± 6.4 years. Exclusion criteria were glaucoma and concomitant retinal pathology. The mean value of best corrected visual acuity was 0.28 ± 0.07. The mean retinal thickness in the fovea was 417 ± 70 µm. Vitrectomy was performed with installation of two ports in the opposite quadrants – in the lower half for high-flow cannula (illuminator-chandelier built with infusion cannula), in the upper half for vitrectomy cutter and instruments. The High-Flow infusion cannula (Synergetics) integrated with the mercury vapor illuminator-chandelier is connected to the Photon II illumination system (Synergetics). Surgery was performed classically: central vitrectomy, separation of posterior hyaloid membrane, staining of membranes with vitral dye, membrane removal, tamponade ⅓ of vitreous cavity with sterile air. The average operation time was 18 minutes. Results. Six months after the operative treatment all patients noted reduction of visual discomfort and severity of metamorphopsies. Best corrected visual acuity was increased – 0.58 ± 0.1 (p ≤ 0,05 vs. preoperative values). Average retinal thickness in the fovea after surgical treatment decreased to 261 ± 25 µm according to macular OCT chart (p = 0.03). FCM readings were consistent with preoperative 5.1 ± 2.3 f/ms (p ≤ 0.01). Conclusion. The method of two-port vitrectomy with the use of mercury vapor chandeleur in the treatment of vitreomacular pathology allows safe and effective macular surgery. Keywords: retinophototoxicity, vitrectomy, epiretinal fibrosis","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85943513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posterior segment of the eyeball: clinical case of chronic central serous chorioretinopathy 眼球后段:慢性中枢性浆液性脉络膜视网膜病变1例
Pub Date : 2023-03-28 DOI: 10.25276/2312-4911-2023-1-331-337
S. Naidenova, E. Lutsai, I. V. Astafyev
Central serous chorioretinopathy is most often found in able-bodied men of young and middle age. The aim of the study: to improve the quality and efficiency of medical care for patients with chronic central serous chorioretinopathy. A clinical example. Patient D., 46 years old, applied in May 2022. Treatment of this pathology is carried out according to the standards of specialized medical care in the field of ophthalmology, approved by the Ministry of Health of the Russian Federation. The clinical anatomy of the posterior segment of the eyeball is the basis for assessing various types of pathology, including chronic central serous chorioretinopathy. Diagnostics with visualization of layers in the area of the posterior segment of the eyeball is predominant among the research methods. Treatment in accordance with the standards of medical care leads to the restoration of the anatomical noma of the structures of the posterior segment of the eyeball. Keywords: posterior segment of the eyeball, human anatomy, central serous chorioretinopathy
中枢性浆液性脉络膜视网膜病变常见于身体健全的青年和中年男性。目的:提高慢性中枢性浆液性脉络膜视网膜病变患者的医疗服务质量和效率。一个临床的例子。D患者,46岁,于2022年5月申请。这种疾病的治疗是按照俄罗斯联邦卫生部批准的眼科专业医疗标准进行的。眼球后段的临床解剖是评估各种类型病理的基础,包括慢性中枢性浆液性脉络膜视网膜病。在研究方法中,眼球后段区域的分层可视化诊断占主导地位。按照医疗护理标准进行治疗,可恢复眼球后段结构的解剖瘤。关键词:眼球后段,人体解剖学,中心性浆液性脉络膜视网膜病变
{"title":"Posterior segment of the eyeball: clinical case of chronic central serous chorioretinopathy","authors":"S. Naidenova, E. Lutsai, I. V. Astafyev","doi":"10.25276/2312-4911-2023-1-331-337","DOIUrl":"https://doi.org/10.25276/2312-4911-2023-1-331-337","url":null,"abstract":"Central serous chorioretinopathy is most often found in able-bodied men of young and middle age. The aim of the study: to improve the quality and efficiency of medical care for patients with chronic central serous chorioretinopathy. A clinical example. Patient D., 46 years old, applied in May 2022. Treatment of this pathology is carried out according to the standards of specialized medical care in the field of ophthalmology, approved by the Ministry of Health of the Russian Federation. The clinical anatomy of the posterior segment of the eyeball is the basis for assessing various types of pathology, including chronic central serous chorioretinopathy. Diagnostics with visualization of layers in the area of the posterior segment of the eyeball is predominant among the research methods. Treatment in accordance with the standards of medical care leads to the restoration of the anatomical noma of the structures of the posterior segment of the eyeball. Keywords: posterior segment of the eyeball, human anatomy, central serous chorioretinopathy","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88741255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Modern technologies in ophtalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1